BRCA1/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7217
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
BRCA1/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy ; volume:109 ; number:3 ; day:3 ; month:8 ; year:2007 ; pages:507-514 ; date:6.2008
Breast cancer research and treatment ; 109, Heft 3 (3.8.2007), 507-514, 6.2008
- Creator
-
Schlich-Bakker, Kathryn J.
Ausems, Margreet G. E. M.
Schipper, Maria
Kroode, Herman F. J. ten
Wárlám-Rodenhuis, Carla C.
Bout, Jan van den
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10549-007-9680-y
- URN
-
urn:nbn:de:101:1-2021090318523705816444
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schlich-Bakker, Kathryn J.
- Ausems, Margreet G. E. M.
- Schipper, Maria
- Kroode, Herman F. J. ten
- Wárlám-Rodenhuis, Carla C.
- Bout, Jan van den
- SpringerLink (Online service)
Other Objects (12)
Identification of patients at high risk of negative psychological consequences associated with BRCA1 mutation
Association of radiotherapy with preferential depletion of luminal epithelial cells in a BRCA1 mutation carrier
Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specific
Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancer
BRCA1 Mutation: An Insidious Enemy with Multiple Facets…
Survival in Norwegian BRCA1 mutation carriers with breast cancer
BRCA1 mutation in the Triple- Negative Breast Cancer Group
BRCA1 germline mutation and glioblastoma development: report of cases
Pregnancy after breast cancer in BRCA1/2 mutation carriers
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer
A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment
BRCA1 and BRCA2 germline mutation analysis in the Indonesian population
Identification of patients at high risk of negative psychological consequences associated with BRCA1 mutation
Association of radiotherapy with preferential depletion of luminal epithelial cells in a BRCA1 mutation carrier
Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specific
Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancer
BRCA1 Mutation: An Insidious Enemy with Multiple Facets…
Survival in Norwegian BRCA1 mutation carriers with breast cancer
BRCA1 mutation in the Triple- Negative Breast Cancer Group
BRCA1 germline mutation and glioblastoma development: report of cases
Pregnancy after breast cancer in BRCA1/2 mutation carriers
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer
A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment
BRCA1 and BRCA2 germline mutation analysis in the Indonesian population
Identification of patients at high risk of negative psychological consequences associated with BRCA1 mutation
Association of radiotherapy with preferential depletion of luminal epithelial cells in a BRCA1 mutation carrier
Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specific
Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancer
BRCA1 Mutation: An Insidious Enemy with Multiple Facets…
Survival in Norwegian BRCA1 mutation carriers with breast cancer
BRCA1 mutation in the Triple- Negative Breast Cancer Group
BRCA1 germline mutation and glioblastoma development: report of cases
Pregnancy after breast cancer in BRCA1/2 mutation carriers
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer
A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment